4th Quarter - Report
OGR for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
Firm
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General prescription drug affordability and access.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN | — |
| MICHAEL DEE BUCHANAN | — |
| CHRIS GIBLIN | — |
| KARISSA WILLHITE | — |
Medicare/Medicaid MMM
Provisions related to Part D access and drug pricing negotiation. Compulsory licensing policy issues. H.R.1046, Medicare Negotiation and Competitive Licensing Act of 2019. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN | — |
| MICHAEL DEE BUCHANAN | — |
| CHRIS GIBLIN | — |
| KARISSA WILLHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.